Advertisement

Topics

"Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment" Drugs and Medication Database

06:07 EST 16th February 2019 | BioPortfolio

Here are the most relevant "Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment" Drugs and Medications that we have found in our database.

More Information about "Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment" on BioPortfolio

We have published hundreds of Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment news stories on BioPortfolio along with dozens of Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment Clinical Trials and PubMed Articles about Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment Companies in our database. You can also find out about relevant Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment Drugs and Medications on this site too.

Showing "Reata Announces Initiation Phase Study Bardoxolone Methyl Treatment" Drugs and Medications, all 6

Possibly Relevant

Iclusig [millennium pharmaceuticals, inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

Amlodipine besylate [stat rx usa llc]

Amlodipine Besylate Tablets Rx only

Nicardipine hydrochloride [pharmaforce, inc.]

Nicardipine Hydrochloride Injection

Nicardipine hydrochloride [wockhardt usa llc.]

Nicardipine Hydrochloride Injection, USP Rx only

Nicardipine hydrochloride [wockhardt limited]

Nicardipine Hydrochloride Injection Rx only

Sentradine [physician therapeutics llc]

Sentradine



Advertisement
Quick Search
Advertisement
Advertisement